Test deployed on Quanterix’ Ultrasensitive Simoa® platform improves sensitivity and specificity for measuring immune response and seroconversion earlier and with higher resolution Non-exclusive agreement with Brigham and Women’s Hospital licensed technology to conduct serological assay to address unmet needs in the clinical setting, epidemiological studies, and for therapeutic and vaccine development BILLERICA, Mass.– Quanterix Corporation (NASDAQ: QTRX), […]

MINNEAPOLIS — Bio-Techne Corporation (NASDAQ:TECH) today announced the release of the GMP Cloudz™ Human T Cell Activation Kit. This is the first GMP-grade kit within the Cloudz product line addressing the need for robust, yet safe products within the clinical- and commercial-scale of the Cell and Gene Therapy manufacturing process. The kit contains Cloudz particles, […]

Merck KGaA, Darmstadt, Germany today announced that two of its Life Science business’ CRISPR-assisted genome-editing patents have been allowed in the United States. Technology provides more tools to fight difficult-to-treat diseases Life Science business actively licensing its CRISPR-Cas9 technology for therapeutic and other uses Committed to ethical use of genome-editing technology Merck KGaA, Darmstadt, Germany, […]

BRANFORD, Conn. — IsoPlexis, the leader in functional cellular proteomics, today announced the appointment of John Strahley as Chief Financial Officer. As CFO, Mr. Strahley will be responsible for the company’s strategic planning, finance, accounting, investor relations, and treasury functions, among other pivotal roles. “We look forward to welcoming John to IsoPlexis’ executive leadership team,” said Sean Mackay, […]

SHANGHAI, China — Burning Rock and Illumina (NASDAQ: ILMN), a global leader in gene sequencing and array-based technologies, jointly announced today that they are joining forces to promote the development and standardization of NGS-based cancer therapy selection in China based on Illumina’s NextSeqTM 550Dx system. In 2015, Illumina’s sequencing technology and Burning Rock’s development and commercial capabilities were for […]

Blue-Ray Biotech Corporation, a professional PCR instrument manufacturer, today releases its real-time PCR system, the TurboQ. Designed for multiplex PCR and routine detection with versatile features, TurboQ can greatly help bio-scientists and clinical lab practitioners in performing COVID-19 diagnostic testing and researches. Mr. Fed Chu, Sales Manager of Blue-Ray Biotech, explains why the company is […]

Mérieux Equity Partners and Korys announce the launch of a new investment platform in Venture Capital to support innovative companies in the healthcare and nutrition sectors, in Europe and North America. OMX Europe Venture Fund FPCI (“OMX Europe”) was launched with a significant financial commitment representing more than two thirds of the target size of […]

Company to provide 50 Ion Torrent Genexus Systems for consortia members at a subsidized price to support global COVID-19 research CARLSBAD, Calif. — To accelerate national, multi-institutional efforts focused on mapping coronavirus transmission and epidemiological studies, Thermo Fisher Scientific today announces the SARS-CoV-2 GlobalAccess Sequencing Program for research consortia and industry groups battling the spread of the […]

AMSBIO has extended its COVID-19 research portfolio with the introduction of a service to provide custom lentivirus pseudotyped with spike glycoprotein from SARS-CoV-2 to help researchers identify potential targets for development of therapeutic drugs and vaccines. Various research groups around the world have demonstrated that SARS-CoV-2 uses its spike glycoprotein S, a main target for neutralization […]

NEWARK, Calif. — Intabio, Inc., a developer of analytical solutions that provide profound efficiency gains across all stages of biopharmaceutical development and manufacturing, today announced the launch of its new website providing fresh information about Intabio’s Blaze™ iCIEF-MS system. The new website features updated product information and a detailed look into Blaze’s proprietary microchip-based technology. Commercial launch […]